Traditional Chinese medicine for treating benign prostatic hyperplasia with dysfunction of detrusor

Abstract

The invention relates to a traditional Chinese medicine for treating benign prostatic hyperplasia with dysfunction of detrusor. The traditional Chinese medicine is prepared from the following components by weight: 30-40g of astragalus membranaceus, 20-30g of artemisia anomala, 15-25g of cornus officinalis, 15-25g of achyranthes roots and 30-40g of herba patriniae by the steps of mixing the medicinal raw materials, soaking with water, decocting and boiling with strong fire, decocting with slow fire and filtering to obtain primary filtrate; adding water into the decoction dreg, decocting and boiling with strong fire, decocting with slow fire, and filtering to obtain secondary filtrate; and mixing the two filtrates, and concentrating. The traditional Chinese medicine is prepared from purely natural traditional Chinese medicinal herbs, is synergistic and reasonable in preparation due to organic combination of the medicinal materials. The traditional Chinese medicine has rich and easily available raw materials, excellent curative effect and low cost, and is a great innovation in medicines for treating benign prostatic hyperplasia with dysfunction of detrusor with symptoms of weakened body resistance and stasis obstruction, and has remarkable economic and social benefits.

Description

technical field [0001] The invention relates to medicine, in particular to a traditional Chinese medicine for treating benign prostatic hyperplasia and bladder detrusor dysfunction. Background technique [0002] Benign prostatic hyperplasia (benign prostatic hyperplasia, BPH) is a common disease in middle-aged and elderly men. The incidence of the disease is on the rise. The main clinical manifestations of BPH are lower urinary tract symptoms such as frequent urination, urgency, dysuria, nocturia and urinary retention, which may affect the function of the kidneys over time, resulting in renal insufficiency, seriously affecting the quality of life of patients and even threatening their lives. [0003] Urethral obstruction caused by benign prostatic hyperplasia is the initial cause of the disease, followed by compensatory enhancement and hypertrophy of the detrusor muscle of the bladder, and eventually detrusor muscle decompensation, impaired contractile function, and dysuria...

AI Technical Summary

Problems solved by technology

[0004] In view of the above-mentioned situation, in order to overcome the above-mentioned defects, the present invention guides BPH detrusor muscle contraction dysfunction according to the theory of "deficiency, loss, and accumulation", and proposes the treatment method and rule of "strengthening and resolving accumulation", and establishes "righting and resolving accumulation". According to this, a traditional Chinese medicine for treating benign prostatic hyperplasia with bladder detrusor dysfunction is provided, which can effectively solve the problem of ineffective treatment of positive deficiency and stasis type benign prostatic hyperplasia with bladder detrusor dysfunction

Images